Literature DB >> 11317187

Lipid second messenger regulation: the role of diacylglycerol kinases and their relevance to hypertension.

J Ohanian1, V Ohanian.   

Abstract

Extracellular stimuli elicit cellular responses through generation of intracellular second messengers. The lipid second messenger diacylglycerol is produced following activation of the phosphoinositide signalling system. Diacylglycerol is the physiological activator of protein kinase C but also interacts indirectly with other signalling molecules such as small G proteins. Diacylglycerol kinases convert diacylglycerol to phosphatidic acid so terminating signalling through diacylglycerol. However, phosphatidic acid itself has a lipid second messenger role, with targets distinct from those of its precursor diacylglycerol. Therefore, diacylglycerol kinases occupy a central position in signal transduction and regulation of their activity is crucial to cellular function. A family of nine mammalian diacylglycerol kinases have been identified. Their structural diversity and complex pattern of tissue expression suggests that they function in distinct cellular processes. In addition to the plasma membrane, diacylglycerol kinases are found at the nucleus and cytoskeleton and translocation between subcellular compartments occurs with agonist stimulation. In small arteries diacylglycerol kinase activity is increased by adrenergic stimulation implying a role in vascular smooth muscle responses. Due to their role as key regulators of protein kinase C activity diacylglycerol kinases may play a role in the cardiovascular changes that occur in hypertension and as such could represent novel therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11317187     DOI: 10.1038/sj.jhh.1001139

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  10 in total

1.  Novel diacylglycerol kinase inhibitor selectively suppressed an U46619-induced enhancement of mouse portal vein contraction under high glucose conditions.

Authors:  Koji Nobe; Mari Miyatake; Hiromi Nobe; Yasushi Sakai; Junko Takashima; Kazutaka Momose
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

2.  Protein acylation in the cardiac muscle like cell line, H9c2.

Authors:  Danny M Hasselbaink; Theo H M Roemen; Ger J van der Vusse
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

3.  Novel strategies for enhancing shotgun lipidomics for comprehensive analysis of cellular lipidomes.

Authors:  Changfeng Hu; Chunyan Wang; Lijiao He; Xianlin Han
Journal:  Trends Analyt Chem       Date:  2018-11-27       Impact factor: 12.296

4.  A comparative metabolomics study on anadromous clupeid Tenualosa ilisha for better understanding the influence of habitat on nutritional composition.

Authors:  Satabdi Ganguly; Tandrima Mitra; Arabinda Mahanty; Sasmita Mohanty; Bimal P Mohanty
Journal:  Metabolomics       Date:  2020-02-25       Impact factor: 4.290

5.  R59949, a diacylglycerol kinase inhibitor, inhibits inducible nitric oxide production through decreasing transplasmalemmal L-arginine uptake in vascular smooth muscle cells.

Authors:  Tomoko Shimomura; Tomoyuki Nakano; Kaoru Goto; Ichiro Wakabayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-01       Impact factor: 3.000

6.  Characterization and quantification of diacylglycerol species in biological extracts after one-step derivatization: a shotgun lipidomics approach.

Authors:  Miao Wang; Jun Hayakawa; Kui Yang; Xianlin Han
Journal:  Anal Chem       Date:  2014-01-28       Impact factor: 6.986

7.  Global Changes in Lipid Profiles of Mouse Cortex, Hippocampus, and Hypothalamus Upon p53 Knockout.

Authors:  Sang Tak Lee; Jong Cheol Lee; Jong Whi Kim; Soo Young Cho; Je Kyung Seong; Myeong Hee Moon
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

Review 8.  DGK-θ: Structure, Enzymology, and Physiological Roles.

Authors:  Becky Tu-Sekine; Hana L Goldschmidt; Daniel M Raben
Journal:  Front Cell Dev Biol       Date:  2016-09-14

9.  α-Isocubebene modulates vascular tone by inhibiting myosin light chain phosphorylation in murine thoracic aorta.

Authors:  Byeong Hyeok Ye; Eun Jung Kim; Seung Eun Baek; Young Whan Choi; So Youn Park; Chi Dae Kim
Journal:  Korean J Physiol Pharmacol       Date:  2018-06-25       Impact factor: 2.016

10.  Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis.

Authors:  Chao Huang; Jiefeng Zhao; Chen Luo; Zhengming Zhu
Journal:  Front Med (Lausanne)       Date:  2020-07-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.